羟氯喹在系统性红斑狼疮、抗SSA/SSB抗体及抗磷脂抗体阳性妊娠中的应用
本综述汇总羟氯喹在系统性红斑狼疮、抗SSA/SSB抗体或抗磷脂抗体阳性妊娠中的最新证据。羟氯喹可减少系统性红斑狼疮复发、降低抗SSA/SSB阳性妊娠先天性心脏传导阻滞复发风险,并可能作为抗磷脂抗体患者的辅助治疗。标准剂量(≤400 mg/天)未显示与先天畸形一致相关,妊娠期血药浓度过低可能与母体疾病活动度更高及不良妊娠结局相关。
要点
- 羟氯喹可减少系统性红斑狼疮妊娠期复发,并降低抗SSA/SSB阳性妊娠先天性心脏传导阻滞复发风险。
- 抗磷脂抗体阳性患者中,羟氯喹可能作为辅助治疗减轻产科并发症,尤其难治性病例。
- 标准剂量(≤400 mg/天)未显示与先天畸形一致相关,妊娠期血药浓度过低主要用途是识别不依从。
核心结论
- 羟氯喹在系统性红斑狼疮、抗SSA/SSB抗体或抗磷脂抗体阳性妊娠中具有重要作用,可改善妊娠结局。
- 新兴证据支持羟氯喹减少系统性红斑狼疮复发并降低抗SSA/SSB阳性妊娠先天性心脏传导阻滞复发风险。
- 在抗磷脂抗体阳性患者中,羟氯喹可能作为辅助治疗减轻产科并发症,尤其难治性病例。
研究设计与样本
- 本综述汇总羟氯喹在妊娠期应用的最新信息,以帮助指导临床决策。
主要发现
- 系统性红斑狼疮、抗SSA/SSB抗体或抗磷脂抗体阳性妊娠患者不良妊娠结局风险升高,包括子痫前期、早产和先天性心脏传导阻滞。
- 大型队列研究和国际指南确认羟氯喹在标准剂量(≤400 mg/天)下安全,未显示与先天畸形一致相关。
- 近期研究提示妊娠期羟氯喹血药浓度低于治疗水平可能与母体疾病活动度更高及不良妊娠结局相关。
- 妊娠期羟氯喹血药浓度检测目前主要用途是识别不依从。
临床怎么用
- 鉴于该人群妊娠并发症风险升高,患者及其多学科诊疗团队需清楚理解羟氯喹的关键作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloroquine (HCQ) plays a pivotal role due to its immunomodulatory and antithrombotic properties, which may help improve pregnancy outcomes. Emerging evidence supports HCQ's role in reducing SLE flares, as well as lowering the recurrence risk of congenital heart block in anti-SSA/SSB-positive pregnancies. Additionally, in patients with antiphospholipid antibodies, HCQ may serve as an adjunctive therapy to mitigate obstetric complications, particularly in refractory cases. Despite early concerns about teratogenicity, large cohort studies and international guidelines affirm HCQ's safety at standard doses (≤400 mg/day), with no consistent association with congenital malformations (CMs). Recent research suggests that subtherapeutic HCQ blood levels during pregnancy may correlate with higher maternal disease activity and adverse pregnancy outcomes, though their primary utility currently lies in identifying nonadherence. Given the heightened risk of pregnancy complications in this population, a clear understanding of HCQ's essential role is crucial for both patients and their multidisciplinary care teams. This review provides up-to-date information on HCQ in pregnancy to help guide clinical decision-making.
引用
- Saleh ZF, Somers EC, Romero VC, et al. Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies. Am J Obstet Gynecol. 2025. PMID: 40930382. doi:10.1016/j.ajog.2025.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。